Ticker
ANTHEM
Analysis
Anthem Biosciences Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to ANTHEM.
Anthem Biosciences Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to ANTHEM.
ANTHEM
Stock
$4.76B
Health Technology
Biotechnology
INR
Anthem Biosciences Limited may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Anthem Biosciences Limited has informed the Exchange regarding a revised press release for the quarter and financial year ended March 31, 2026.
Anthem Biosciences Limited has informed the Exchange regarding a press release for the quarter and the financial year ended March 31, 2026.
Submission of Press Release for the Financial Results for the quarter and nine months ended December 31, 2025 in machine readable format.
Press release for the financial results for the quarter and nine months ended December 31, 2025.
Anthem Biosciences Limited has informed the Exchange regarding a press release dated November 08, 2025, titled "Financial result for quarter and half year ended September 30, 20...
Review valuation context for Anthem Biosciences Limited.
Review future growth context for Anthem Biosciences Limited.
Review past performance context for Anthem Biosciences Limited.
Review financial health context for Anthem Biosciences Limited.
Review dividend context for Anthem Biosciences Limited.
Review management context for Anthem Biosciences Limited.
Review ownership context for Anthem Biosciences Limited.
Review other information context for Anthem Biosciences Limited.
Review community context for Anthem Biosciences Limited.